According to a new study by researchers at the University of Illinois Chicago, approximately 3 in 20 health care workers surveyed reported being hesitant about getting their COVID-19 vaccinations. The study also showed workers’ vaccine decisions were likely to be influenced by their colleagues.
As the first cases of flu are reported in Los Angeles this season, public health experts are urging anyone who isn't already vaccinated to get the flu shot. It's the best protection against the flu, which could pummel the U.S. this winter after nearly disappearing last year.
Boys are 10 times more likely to be vaccinated against human papillomavirus (HPV) in provinces where the vaccine is publicly funded than in places where it is not, according to a new study published by a researcher at the Princess Margaret Cancer Centre and colleagues at McGill University, Université de Montréal, and the Jewish General Hospital.
Kim Iversen, a popular political talk show host with over 27K followers on Twitter, claimed that people who are fully vaccinated against COVID-19 are global superspreaders of the new omicron variant. “I can’t believe that after fully vaccinated travelers have been found to be the global spreaders of the omicron variant, we’re STILL talking about forcing people into being vaccinated,” she wrote on Twitter. We find this claim to be misleading. There is very little data on how the new variant is being spread.
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, today announced a partnership with CLEAR (NYSE: YOU), the secure identity company, to empower patients with a digital proof of their COVID-19 vaccination records. Patients vaccinated at Hackensack Meridian Health can now use the free CLEAR app and digital vaccine card feature - replacing their fragile paper card with a verified digital version that can be used anywhere and anytime needed.
Scientists at La Jolla Institute for Immunology (LJI) and Massachusetts Institute of Technology (MIT), have found a possible way to improve the effectiveness of COVID-19 vaccines—and any vaccine.
November 18, 2021 – Chulalongkorn University held Chula The Impact 5 Seminar on “The Progress on ChulaCov19 — an mRNA vaccine by Thais — the World’s Hope“. Also discussed was the progress of Chula-Baiya, Thailand’s first protein subunit vaccine from tobacco leaves by Baiya Phytofarm Co., Ltd., and Faculty of Pharmaceutical Sciences, Chulalongkorn University.
A new opinion piece published online in the Annals of the American Thoracic Society provides an exhaustive examination of the ethics of using hospital resources on unvaccinated-by-choice COVID-19 pneumonia patients, versus patients with other serious illnesses whose diseases are not progressing as quickly.
Patients whose immune systems are weakened due to cancer, organ or bone marrow transplants, chronic diseases, or the medications used to treat these conditions may feel like they have enough on their plates without worrying about whether and when they should take an additional dose of COVID-19 vaccine and a flu shot.
Researchers at Moffitt Cancer Center are working to develop a dendritic cell vaccine targeting HER3, a protein involved in the growth and spread of many different cancer types. Their pre-clinical work has been published in the journal Cancer Immunology Research.
Kizzmekia S. Corbett, well known for her work on the mRNA vaccines used to protect against Covid-19, has been named the recipient of the 2021 E.E. Just Award by the ASCB.
Dec. 1, 2021— People living with HIV experience more severe outcomes and have higher comorbidities from COVID-19 than people not living with HIV, according to the 2020 UNAIDS Global Update. In mid-2021, most people living with HIV did not have access to COVID-19 vaccines. This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is calling on governments, health advocates and non-government organisations to strengthen their response to AIDS and COVID-19 by making COVID-19 vaccines more accessible worldwide.
UC San Diego nanoengineers developed a new and potentially more effective way to deliver messenger RNA (mRNA) into cells. Their approach involves packing mRNA inside nanoparticles that mimic the flu virus—a naturally efficient vehicle for delivering genetic material such as RNA inside cells.
Kaiser Permanente research in Southern California published Nov. 25, 2021, in The Lancet Regional Health – Americas confirmed high Moderna COVID-19 vaccine effectiveness up to 5 months after the second dose.
Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years.
A new article published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.
Individuals with kidney failure who were on dialysis had an incomplete and delayed antibody response and a blunted cellular immune response following COVID-19 vaccination, compared with people with normal kidney function.
A new study summarized in a research letter to be published in JAMA Pediatrics reveals that a number of factors, including negative impacts from the pandemic during pregnancy and reports of discrimination, made it less likely that infants received their recommended vaccinations in the first months of their lives.
While cases appear to have fallen in Uttar Pradesh as well as most locations in India, it’s not clear why. Many other factors, including immunity from a previous infection, vaccination, and lockdowns, likely helped reduce the number of cases.
The Institute for Molecular Medicine will advance the manufacturing of Duvax for the first clinical trials of a dual vaccine for Alzheimer's disease to begin in 2023
Cedars-Sinai physicians who have been on the front lines in the battle against COVID-19 in the community are also doing their part at home by getting their children vaccinated against the virus.
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus's delta variant continues to spread.
As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
A virtual workshop for users of the Advanced Photon Source and the Center for Nanoscale Materials highlighted pioneering research to understand the SARS-CoV-2 virus and its variants that cause COVID-19.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) conducted a head-to-head test of the second-generation vaccine CV2CoV compared with CVnCoV. The scientists assessed the vaccines’ ability to provoke an immune response as well as their protective efficacy against COVID-19 in non-human primates.
Loyola Medicine is now offering the COVID-19 vaccine to children ages 5 to 11 at multiple clinic sites, including mobile vaccine clinics. The Pfizer COVID-19 vaccine was authorized for emergency use for children ages 5 to 11. It is a two-dose series taken three weeks apart. Each dose will be 1/3 the dosage of the adolescent/adult vaccine.
A randomized controlled trial of 2,275 women in Kenya showed that a single dose of the HPV vaccine was highly effective. The current standard for women is three doses. This news could greatly hasten the pace of vaccinations and brings renewed energy to make cervical cancer the first cancer to be wiped out.
Research by UCLA Fielding School's UCLA Center for Health Policy Research, led by Dr. Ninez Ponce, Fielding School professor of health policy and management, found that Californians have varied their COVID-19 risk reduction based on their test results
Iowa State University researchers were part of a team evaluating possible strategies the CDC could have recommended last winter for COVID-19 vaccine rollouts.
Wealthier nations should pay a COVID-19 vaccine tax as part of the price they pay to manufacturers, to ensure a fairer distribution of the jab to poorer nations, argues a political scientist in the Journal of Medical Ethics.
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced its plenary speakers for Virtual ISPOR Europe 2021 scheduled for 30 November - 3 December.
A survey of parents and caregivers of children with cancer found that nearly a third of them expressed hesitancy to vaccinate their youngsters against COVID-19.
Close to 10 million children in lower-income countries have never been vaccinated against any infectious disease. These “zero-dose” kids hold a lesson for all of us, says Canadian public-health expert Mira Johri.
New research from McMaster University, aimed at understanding the immune response to COVID-19 vaccines, found some long-term care residents no longer had high antibody levels months after their second dose, directly supporting government decisions to provide third doses.
A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes produced by people who received either of the two available messenger RNA (mRNA) vaccines for COVID-19 persist six months after vaccination at only slightly reduced levels from two weeks after vaccination.
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center (MECC). The findings, published online today in Cancer Cell, also show that a “booster” shot is extremely beneficial for all cancer patients, who face a heightened risk of severe disease and dying from COVID-19, and particularly in people who have a blood cancer.
If you got the COVID-19 shots back in early spring, your antibodies are likely waning. But it’s not something you need to be worried about, according to a new study from the University of Georgia.
With the holiday season here, and COVID-19 vaccines rolling out to millions of American children 5-11 years old, celebrations could look a little different this year compared to the scaled back or cancelled holiday plans in 2020. While experts say small gatherings for those who are vaccinated can be safe for the holidays this year, a new national survey conducted by The Ohio State University Wexner Medical Center found many Americans still plan to celebrate very cautiously.
Austria will impose a nationwide lockdown for people who have not been vaccinated against COVID-19. Will it be the first country in the world to do so? Not entirely.
For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.